Navigation Links
LifeCare Holdings, Inc. Announces First Quarter Results
Date:5/15/2008

ts is included in our Form 10-K as filed on March 28, 2008, as amended, which can be viewed on the SEC's website. Many of the factors that will determine the Company's future results are beyond the ability of management to control or predict. As a result, you should not place undue reliance on forward-looking statements, which reflect management's views only as the date hereof. The Company undertakes no obligation to revise or update any forward- looking statement, or to make any other forward-looking statements whether as a result of new information, future events or otherwise.

Non-GAAP Financial Measures

Credit Agreement EBITDA is used in the calculations of the interest coverage and leverage ratios that are included in the covenants contained in our existing senior secured credit agreement. Credit Agreement EBITDA is not a measure of financial performance computed in accordance with GAAP and should not be considered in isolation or as a substitute for operating income, net income, cash flows from operations or other statement of operations or cash flow data prepared in conformity with GAAP, or as measures of profitability or liquidity. In addition the calculation of Credit Agreement EBITDA is susceptible to varying interpretations and calculation, and the amounts presented may not be comparable to similarly titled measures of other companies. Credit Agreement EBITDA may not be indicative of historical operating results, and we do not mean for it to be predictive of future results of operations or cash flows. For the trailing 12-month period ended March 31, 2008, Credit Agreement EBITDA was $48.6 million, including a $6 million cure exercised for the three-month period ended September 30, 2007.

LifeCare, based in Plano, Texas, operates 19 long-term acute care hospitals located in nine states. Long-term acute care hospitals specialize in the treatment of medically complex patients who typically require extended hospitalization. For more informa
'/>"/>

SOURCE LifeCare Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. LifeCare Holdings, Inc. Announces Third Quarter Results
2. LifeCare Hospitals of Wisconsin Unveils Center for Advanced Wound Healing
3. LifeCare Holdings, Inc. Announces Year-end Results
4. LifeCare Holdings, Inc. Names McAlister Chairman and CEO
5. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
6. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
7. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
8. Platinum Underwriters Holdings, Ltd. to Report Third Quarter 2007 Results on October 23, 2007
9. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
10. NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call
11. China Shenghuo Pharmaceutical Holdings, Inc. Opens Showcase 12Ways(R) Chinese Herbal Beauty Salon in October
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...ough the number of jobs created in the medical fie...ed a different kind of slowdown: they laid off few... Seattle, WA (PRWEB) July 25, 2...dical field slowed in June overall, pharmaceutical...hat will be music to the ears of sales representat...
(Date:7/25/2008)...f Marketing Exclusivity Begins -, CORONA, Calif.,...uticals, Inc. (NYSE: WPI ), a leading specialty p...bsidiary has commenced commercial,shipment of its ... the 40mg,strength from its Davie, Florida manufac...atson has 180 days of marketing exclusivity for be...
(Date:7/25/2008)...5 /PRNewswire/ -- Sagent Pharmaceuticals, Inc.,a ...oday announced that it,has launched amiodarone HCl...ted for the treatment and prophylaxis of frequentl...ically unstable ventricular,tachycardia -- a poten...nt,s amiodarone HCl injection will be available im...
(Date:7/25/2008)...5 /PRNewswire/ -- AutoGenomics, Inc. today,announc...orm S-1 with the,Securities and Exchange Commissio... of shares of its common stock. The number of shar... expected to be offered by,AutoGenomics, Inc., and...en,determined., J.P. Morgan Securities Inc. is ac...
Breaking Medicine News(10 mins):Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 2Health News:Sagent Pharmaceuticals Launches Amiodarone HCl Injection, USP 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2
...vouch for the difficulty of capturing a clear pict...es, however, sometimes the motion is exactly what ...d the pathological protein mis-folding and assembl... a host of human disorders, including diabetes and...
...merican research, there is still hope for the couc...urch, director of the Laboratory of Preventive Med...ch Center at Louisiana State University, shows tha...d daily exercise dose, a substantial and immediate...
... the outrage over an insensitive caption for the p...lia, comes the news that a pre-schooler was found...al for unwanted babies. The drop-off was opened b...e southern city of Kumamoto to discourage abortion...
...g Administration (FDA) today approved Evicel Fibri...cally helps control oozing from small blood vesse...n effective means to stop oozing from small vessel...ring, compression or other standard techniques are...
Other Medicine News:Health News:Decoding Protein Structures Helps Illuminate Cause of Diabetes 2Health News:Spare Just Ten Minutes A Day For A Healthier Heart 2Health News:Three-year-old Abandoned in Box Meant for Unwanted Babies in Japan 2
(Date:7/24/2008)...eeds Oncology Patient Accrual, DENVER, July 24 /P...ent,Organization (RMO), has contracted with five l...h and site management services for their,clinical ...ategy. The new,trials include the following diseas...Metastatic Breast Cancer, Metastatic Sarcoma, Chro...
(Date:7/23/2008)...in July print edition of Clinical ...uly 23 /- A Roche Diagnostics-sponsor...o-B-type natriuretic peptide,(NT-proBNP) confirms ...cation in predicting the risk of cardiovascular ad...steroidal anti-inflammatory drugs of,the COX inhib...
(Date:7/23/2008).../ -- InCode BioPharmaceutics, Inc.,an emerging bi...al test,results demonstrating the utility of their...e rare chronic blood disorder paroxysmal nocturnal...e presented at the XXII,International Complement W..., The only treatment currently available for PNH ...
(Date:7/22/2008)...-- Nonin Medical, a leading innovator,of physiolog...has entered,the clinical testing phase with its br...aturation. Today,s most common application for thi...egional blood oxygenation,in the brain -- cerebral...an ongoing clinical study at the,Duke University M...
Breaking Medicine Technology:Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 2Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 3Study Reveals Potential for NT-proBNP as a Marker to Predict Cardiovascular Risks From Anti-Inflammatory Drugs 4InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Advanced Energy Consortium will develop micro and nanosensors to boost energy production 2605 1Advanced Energy Consortium will develop micro and nanosensors to boost energy production 2605 2Pelosi Democrats Host Health Care Forum This Morning 9587 1Pelosi Democrats Host Health Care Forum This Morning 9587 2Pelosi Democrats Host Health Care Forum This Morning 9587 3Pelosi Democrats Host Health Care Forum This Morning 9587 4Wisconsin Physicians Service Insurance Corporation Files Suit Against Aurora Health Care and HealthEOS 9583 1Wisconsin Physicians Service Insurance Corporation Files Suit Against Aurora Health Care and HealthEOS 9583 2The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 1The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 2The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 3The Widener University Elder Pennsylvanian Survey Finds Pennsylvanias Baby Boomers Anticipate Working Longer Retiring Later to Help Offset Looming He 9579 4
...stCall/ -- Kosan,Biosciences Incorporated presente...KOS-1584/R1645, an epothilone under,co-development...vity and tolerability in patients with solid tumor...ts (13 of 41,evaluable) including activity in pati...ostate, head and neck and other cancers. Common,to...
... IL, June 04, 2007,/PRNewswire-FirstCall/ - Cardio...ellas Pharma US, Inc. ("Astellas") today,announced...nical,study, called ACT 2. The trial evaluated the...n of vernakalant hydrochloride,("vernakalant (iv)"...al fibrillation or atrial flutter between 24 hours...
Other Medicine Technology:Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 2Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 3Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 4Kosan Presents Phase 1 Data Showing Promising Antitumor Activity,and Safety Profile of Epothilone KOS-1584 at ASCO 5Cardiome And Astellas Announce Positive Results From ACT 2 Trial 2Cardiome And Astellas Announce Positive Results From ACT 2 Trial 3Cardiome And Astellas Announce Positive Results From ACT 2 Trial 4Cardiome And Astellas Announce Positive Results From ACT 2 Trial 5Cardiome And Astellas Announce Positive Results From ACT 2 Trial 6
...ical Professional Diagnostics is a leading provide...IFA and DFA test menu that includes kits for autoi...ll as miscellaneous conjugates and components. Our...t of substrates and kit sizes to choose from. Kit ...
...ical Professional Diagnostics is a leading provide...IFA and DFA test menu that includes kits for autoi...ll as miscellaneous conjugates and components. Our...t of substrates and kit sizes to choose from. Kit ...
...ical Professional Diagnostics is a leading provide...IFA and DFA test menu that includes kits for autoi...ll as miscellaneous conjugates and components. Our...t of substrates and kit sizes to choose from. Kit ...
...ical Professional Diagnostics is a leading provide...IFA and DFA test menu that includes kits for autoi...ll as miscellaneous conjugates and components. Our...t of substrates and kit sizes to choose from. Kit ...
Medicine Products: